Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1975 Jan 1;141(1):11–26. doi: 10.1084/jem.141.1.11

Private specificities of H-2K and H-2D loci as possible selective targets for effector lymphocytes in cell-mediated immunity

PMCID: PMC2190501  PMID: 46906

Abstract

Receptors of effector T lymphocytes of congeneic strains of mice do not recognize public H-2 specificities and react to private H-2 specificities only. This has been established with the use of three tests: direct cytotoxicity assay of immune lymphocytes upon target cells, specific absorption of the lymphocytes on the target cells, and rejection of skin grafts at an accelerated fashion. Immunization with two private H-2 specificities in the system C57BL/10ScSn leads to B10.D2 induces formation of two corresponding populations of effector lymphocytes in unequal proportion: a greater part of them is directed against the private specificity H-2.33 (Kb), while the smaller part is towards H-2.2 (Db) private specificity. These two populations of effector lymphocytes do not overlap, as demonstrated by experiments on their cross-absorption on B10.D2 (R107), B10.D2 (R101), B10.A(2R), and B10.A(5R) target cells, as well as on mixtures of R107 and R101 targets. Following removal of lymphocytes reacting with one of the private H-2 specificities, lymphocytes specific to the other specificity are fully maintained. A mixture of target cells, each bearing one of the two immunizing private specificities, absorbs 100% of the immune lymphocytes and is totally destroyed by them. It is suggested that H-2 antigens are natural complexes of hapten-carrier type, in which the role of hapten is played by public H-2 specifities and that of the carrier determinant by either private H-2 specificities or structures closely linked to them. Various models of steric arrangement of MHC determinants recognized by receptors of effector T lymphocytes are discussed.

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter B. J., Schendel D. J., Bach M. L., Bach F. H., Klein J., Stimpfling J. H. Cell-mediated lympholysis. Importance of serologically defined H-2 regions. J Exp Med. 1973 May 1;137(5):1303–1309. doi: 10.1084/jem.137.5.1303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ax W., Koren H. S., Fischer H. Cytotoxicity of allogeneic lymphocytes sensitized against H-2 antigens in vitro. Exp Cell Res. 1971 Feb;64(2):439–449. doi: 10.1016/0014-4827(71)90098-x. [DOI] [PubMed] [Google Scholar]
  3. BRONDZ B. D. INTERACTION OF IMMUNE LYMPHOCYTES IN VITRO WITH NORMAL AND NEOPLASTIC TISSUE CELLS. Folia Biol (Praha) 1964;10:164–176. [PubMed] [Google Scholar]
  4. Bach F. H., Segall M., Zier K. S., Sondel P. M., Alter B. J., Bach M. L. Cell mediated immunity: separation of cells involved in recognitive and destructive phases. Science. 1973 Apr 27;180(4084):403–406. doi: 10.1126/science.180.4084.403. [DOI] [PubMed] [Google Scholar]
  5. Bach F. H. The major histocompatibility complex in transplantation immunology. Transplant Proc. 1973 Mar;5(1):23–29. [PubMed] [Google Scholar]
  6. Bach F. H., Widmer M. B., Segall M., Bach M. L., Klein J. Genetic and immunological complexity of major histocompatibility regions. Science. 1972 Jun 2;176(4038):1024–1027. doi: 10.1126/science.176.4038.1024. [DOI] [PubMed] [Google Scholar]
  7. Berke G., Amos D. B. Cytotoxic lymphocytes in the absence of detectable antibody. Nat New Biol. 1973 Apr 25;242(121):237–239. doi: 10.1038/newbio242237a0. [DOI] [PubMed] [Google Scholar]
  8. Bonavida B. Studies on the induction and expression of T cell-mediated immunity. I. Blocking of cell-mediated cytolysis by membrane antigens. J Immunol. 1974 Mar;112(3):926–934. [PubMed] [Google Scholar]
  9. Brondz B. D. Complex specificity of immune lymphocytes in allogeneic cell cultures. Folia Biol (Praha) 1968;14(2):115–131. [PubMed] [Google Scholar]
  10. Brondz B. D. Immunologicheskaia spetsifichnost' uskorennogo ottorzheniia transplantata kozhi pri antigennom perekreste v sisteme H-2. Role immunnykh limforsitov i antitel. Biull Eksp Biol Med. 1972 Dec;73(12):61–65. [PubMed] [Google Scholar]
  11. Brondz B. D. Lymphocyte receptors and mechanisms of in vitro cell-mediated immune reactions. Transplant Rev. 1972;10:112–151. doi: 10.1111/j.1600-065x.1972.tb01541.x. [DOI] [PubMed] [Google Scholar]
  12. Brondz B. D., Snegiröva A. E. Interaction of immune lymphocytes with the mixtures of target cells possessing selected specificities of the H-2 immunizing allele. Immunology. 1971 Apr;20(4):457–468. [PMC free article] [PubMed] [Google Scholar]
  13. Brunner K. T., Mauel J., Rudolf H., Chapuis B. Studies of allograft immunity in mice. I. Induction, development and in vitro assay of cellular immunity. Immunology. 1970 Apr;18(4):501–515. [PMC free article] [PubMed] [Google Scholar]
  14. Davie J. M., Paul W. E. Receptors on immunocompetent cells. I. Receptor specificity of cells participating in a cellular immune response. Cell Immunol. 1970 Oct;1(4):404–418. doi: 10.1016/0008-8749(70)90017-1. [DOI] [PubMed] [Google Scholar]
  15. Dishkant I. P., Vedernikov A. A., Egorov I. K. Izuchenie mutatsii H-2 myshei. Soobshchenie III. Serologicheskii analiz mutatsii 504 i proizoshedshikh ot nee rekombinantnykh gaplotipov H-2. Genetika. 1973 Oct;9(10):83–90. [PubMed] [Google Scholar]
  16. Démant P. Genetic requirements for graft-versus-host reaction in mouse. Different efficacy of incompatibility at D- and K-ends of the H-2 locus. Folia Biol (Praha) 1970;16(4):273–275. [PubMed] [Google Scholar]
  17. Démant P. H-2 gene complex and its role in alloimmune reactions. Transplant Rev. 1973;15:162–200. [PubMed] [Google Scholar]
  18. Eijsvoogel V. P., Du Bois R., Melief C. J., Zeylemaker W. P., Raat-Koning L., de Groot-Kooy L. Lymphocyte activation and destruction in vitro in relation to MLC and HL-A. Transplant Proc. 1973 Mar;5(1):415–420. [PubMed] [Google Scholar]
  19. Golstein P., Erik M. D., Svedmyr A. J., Wigzell H. Cells mediating specific in vitro cytotoxicity. I. Detection of receptor-bearing lymphocytes. J Exp Med. 1971 Dec 1;134(6):1385–1402. doi: 10.1084/jem.134.6.1385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Henney C. S., Nordin A. A. Comparisons of the specificities of cell-mediated and humoral immune responses. I. Cytolytic lymphocytes and plaque-forming cells following immunization with dinitrophenylated human IgG. J Immunol. 1971 Jan;106(1):20–28. [PubMed] [Google Scholar]
  21. Häyry P., Andersson L. C., Nordling S., Virolainen M. Allograft response in vitro. Transplant Rev. 1972;12:91–140. doi: 10.1111/j.1600-065x.1972.tb00054.x. [DOI] [PubMed] [Google Scholar]
  22. Katz D. H., Benacerraf B. The regulatory influence of activated T cells on B cell responses to antigen. Adv Immunol. 1972;15:1–94. doi: 10.1016/s0065-2776(08)60683-5. [DOI] [PubMed] [Google Scholar]
  23. Kinne D. W., Simmons R. L. Passive serologic transfer of allograft immunity in immunologically suppressed mice. II. Effect of graft exposure to immune serum in primary hosts. J Immunol. 1971 Mar;106(3):629–634. [PubMed] [Google Scholar]
  24. Klein J., Murphy D. B. The role of "private" and "public" H-2 antigens in skin graft rejection. Transplant Proc. 1973 Mar;5(1):261–265. [PubMed] [Google Scholar]
  25. Klein J., Shreffler D. C. The H-2 model for the major histocompatibility systems. Transplant Rev. 1971;6:3–29. doi: 10.1111/j.1600-065x.1971.tb00457.x. [DOI] [PubMed] [Google Scholar]
  26. Lilly F., Graham H., Coley R. Genetic control of the antibody response to the H-2.2 alloantigen in mice. Transplant Proc. 1973 Mar;5(1):193–196. [PubMed] [Google Scholar]
  27. McKenzie I. F., Snell G. D. Comparative immunogenicity and enhanceability of individual H-2K and H-2D specificities of the murine histocompatibility-2 complex. J Exp Med. 1973 Jul 1;138(1):259–277. doi: 10.1084/jem.138.1.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Meo T., Vives J., Miggiano V., Shreffler D. A major role for the Ir-1 region of the mouse H-2 complex in the mixed leukocyte reaction. Transplant Proc. 1973 Mar;5(1):377–381. [PubMed] [Google Scholar]
  29. Miggiano V. C., Bernoco D., Lightbody J., Trinchieri G., Ceppellini R. Cell-mediated lympholysis in vitro with normal lymphocytes as target: specificity and cross-reactivity of the test. Transplant Proc. 1972 Jun;4(2):231–237. [PubMed] [Google Scholar]
  30. Perlmann P., Holm G. Cytotoxic effects of lymphoid cells in vitro. Adv Immunol. 1969;11:117–193. doi: 10.1016/s0065-2776(08)60479-4. [DOI] [PubMed] [Google Scholar]
  31. Popp D. M. In vivo lymphocyte transformation induced by H-2D and H-2K components of the H-2 locus. Transplant Proc. 1973 Mar;5(1):281–285. [PubMed] [Google Scholar]
  32. Rychlíková M., Démant P., Egorov I. K. Mixed lymphocyte reaction caused by an H-2D mutation (congenic strains-B10.D2 new-B10.504). Folia Biol (Praha) 1972;18(5):360–363. [PubMed] [Google Scholar]
  33. Rychlíková M., Démant P., Iványi P. The predominant role of the K-end of the H-2 locus in lymphocyte transformation in mixed cultures. Folia Biol (Praha) 1970 Jun;16(3):218–221. [PubMed] [Google Scholar]
  34. Schirrmacher V., Wigzell H. Immune responses against native and chemically modified albumins in mice. I. Analysis of non-thymus-processed (B) and thymus-processed (T) cell responses against methylated bovine serum albumin. J Exp Med. 1972 Dec 1;136(6):1616–1630. doi: 10.1084/jem.136.6.1616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Senyk G., Nitecki D., Goodman J. W. Immunogenicity of glucagon: determinants responsible for antibody binding and lymphocyte stimulation. Science. 1971 Jan 29;171(3969):407–408. doi: 10.1126/science.171.3969.407. [DOI] [PubMed] [Google Scholar]
  36. Stulting R. D., Berke G. Nature of lymphocyte-tumor interaction. A general method for cellular immunoabsorption. J Exp Med. 1973 Apr 1;137(4):932–942. doi: 10.1084/jem.137.4.932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Thorsby E. The human major histocompatibility system. Transplant Rev. 1974;18:51–129. [PubMed] [Google Scholar]
  38. Wagner H. The correlation between the proliferative and the cytotoxic responses of mouse lymphocytes to allogeneic cells in vitro. J Immunol. 1972 Sep;109(3):630–637. [PubMed] [Google Scholar]
  39. Widmer M. B., Alter B. J., Bach F. H., Bach M. L. Lymphocyte reactivity to serologically undetected components of the major histocompatibility complex. Nat New Biol. 1973 Apr 25;242(121):239–241. doi: 10.1038/newbio242239a0. [DOI] [PubMed] [Google Scholar]
  40. Widmer M. B., Peck A. B., Bach F. H. Genetic mapping of H-2 LD loci. Transplant Proc. 1973 Dec;5(4):1501–1505. [PubMed] [Google Scholar]
  41. Wilson D. B., Nowell P. C. Quantitative studies on the mixed lymphocyte interaction in rats. IV. Immunologic potentiality of the responding cells. J Exp Med. 1970 Feb;131(2):391–407. doi: 10.1084/jem.131.2.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. ZILBER L. A., LEZHNEVA O. M., BRONDZ B. D. VOSPROIZVEDENIE SPETSIFICHESKOGO PROTIVOOPUKHOLEVOGO IMMUNITETA V IZOLOGICHNO I SISTEME. Biull Eksp Biol Med. 1964 Nov;58:93–99. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES